HDL-C as a new paradigm in atherosclerotic diseases.
Shilpha
S
S
Bairy
K L
KL
D000818:Animals; D050197:Atherosclerosis / Q000188:drug therapy*; D002784:Cholesterol / Q000378:metabolism; D053480:Cholesterol Ester Transfer Proteins / Q000037:antagonists & inhibitors; D008076:Cholesterol, HDL / Q000097:blood*; D004268:DNA-Binding Proteins / Q000819:agonists; D006801:Humans; D008075:Lipoproteins, HDL / Q000378:metabolism; D000071518:Liver X Receptors; D057093:Orphan Nuclear Receptors; D047493:PPAR alpha / Q000819:agonists; D047495:PPAR gamma / Q000819:agonists; D018160:Receptors, Cytoplasmic and Nuclear / Q000819:agonists
C506642:CETP protein, human; D053480:Cholesterol Ester Transfer Proteins; D008076:Cholesterol, HDL; D004268:DNA-Binding Proteins; D008075:Lipoproteins, HDL; D000071518:Liver X Receptors; D057093:Orphan Nuclear Receptors; D047493:PPAR alpha; D047495:PPAR gamma; D018160:Receptors, Cytoplasmic and Nuclear; D002784:Cholesterol